Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,379 across all filing types
Latest filing 2018-11-11 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
Application Proof (1st submission)
Regulatory Filings Classification · 95% confidence The document is an 'Application Proof' for CStone Pharmaceuticals, which is a standard term used in Hong Kong Stock Exchange IPO filings. The structure of the document, including sections like 'History, Development and Corporate Structure', 'Industry Overview', 'Business', 'Financial Information', and 'How to Apply for [REDACTED]', confirms this is a prospectus for an initial public offering. Since the provided categories do not include 'IPO Prospectus', and it is a regulatory filing related to capital raising, 'RNS' (Regulatory Filings) is the most appropriate fallback category.
2018-11-11 English
CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings Classification · 95% confidence The document is an announcement related to continuing connected transactions under the Hong Kong Listing Rules, specifically concerning a sales contract (HVO Sales Contract) between subsidiaries and connected persons. It discusses the contract terms, approval by the board, independent financial adviser opinion, and compliance with listing rules. The document is structured as a regulatory announcement detailing a continuing connected transaction, including background, terms, pricing, and approvals. It does not contain financial statements, earnings data, or detailed financial performance analysis. It is not a full annual or interim report, nor an earnings release or investor presentation. The document is lengthy (15,000 characters) and contains detailed information about the transaction and regulatory compliance, typical of a Regulatory Filing (RNS) under Hong Kong Listing Rules. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2018-11-02 English
Monthly Returns
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, not a full financial report or announcement of voting results. The document length is about 14,764 characters, indicating substantive content rather than a brief announcement. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP), as it provides updates on the company's capital structure changes and share movements.
2018-11-01 English
RESULTS REPORT FOR THE THIRD QUARTER OF 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'RESULTS REPORT FOR THE THIRD QUARTER OF 2018' and contains detailed unaudited financial data for the third quarter ending 30 September 2018. It includes major accounting data, profit and loss figures, earnings per share, and shareholder information. The document references the China Securities Regulatory Commission (CSRC) regulations on quarterly reports and states the reporting period explicitly. The content is consistent with a quarterly financial report rather than a brief announcement or a certification. The length of the document (15,000 characters) and the detailed financial data confirm it is a substantive financial report for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2018
2018-10-26 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2018 SECOND TRANCHE OF MEDIUM TERM NOTES
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of the issuance of the 2018 second tranche of medium term notes by Yanzhou Coal Mining Company Limited. It details the issuance amount, coupon rate, maturity date, and other issuance specifics. The document references prior approvals and registration notices related to financing activities. It is a formal announcement about a financing event, specifically a bond issuance, rather than a full financial report or earnings release. The document length is 4595 characters, which is relatively short and focused on the issuance event. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2018-10-23 English
ANNOUNCEMENT ON THE UNAUDITED OPERATIONAL DATA OF COAL BUSINESS OF THE THIRDQUARTER OF 2018
Regulatory Filings Classification · 90% confidence The document is titled as an announcement on unaudited operational data for the third quarter of 2018. It contains preliminary, unaudited operational data (production and sales volumes) for the coal business, explicitly stating it is a voluntary announcement and the data is unaudited. The document is relatively short (3056 characters) and does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). Instead, it provides a brief operational update with cautionary notes to investors. This fits best with a Capital/Financing Update (CAP) or Regulatory Filings (RNS) category. However, since it is an operational data announcement without financing or capital structure changes, and it is a voluntary announcement of operational data, it aligns best with Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories. Therefore, the classification is RNS with high confidence.
2018-10-22 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.